These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31779810)

  • 21. Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders.
    Klingelhoefer L; Sokolov E; Chaudhuri KR
    J Neural Transm (Vienna); 2014 Aug; 121 Suppl 1():S25-31. PubMed ID: 24696217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinsonism in essential tremor cases: A clinicopathological study.
    Rajput AH; Rajput EF; Bocking SM; Auer RN; Rajput A
    Mov Disord; 2019 Jul; 34(7):1031-1040. PubMed ID: 31180613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical parkinsonian syndromes].
    Beal C; Durif F
    Rev Prat; 2021 Oct; 71(8):875-883. PubMed ID: 35147346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localizing parkinsonism based on focal brain lesions.
    Joutsa J; Horn A; Hsu J; Fox MD
    Brain; 2018 Aug; 141(8):2445-2456. PubMed ID: 29982424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V; Weiner WJ
    Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
    Caparros-Lefebvre D; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.
    Turcano P; Mielke MM; Josephs KA; Bower JH; Parisi JE; Boeve BF; Savica R
    Mov Disord; 2017 Oct; 32(10):1439-1446. PubMed ID: 28843020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Differential Diagnosis and Treatment of Atypical Parkinsonism.
    Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU
    Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystonia in atypical parkinsonian disorders.
    Marsili L; Bologna M; Kojovic M; Berardelli A; Espay AJ; Colosimo C
    Parkinsonism Relat Disord; 2019 Sep; 66():25-33. PubMed ID: 31443953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestations of Parkinson's disease and parkinsonism.
    Hobson DE
    Can J Neurol Sci; 2003 Mar; 30 Suppl 1():S2-9. PubMed ID: 12691471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism: heterogeneity of a common neurological syndrome.
    Bohlhalter S; Kaegi G
    Swiss Med Wkly; 2011; 141():w13293. PubMed ID: 22052571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The etiopathogenetic and pathophysiological spectrum of parkinsonism.
    Bologna M; Truong D; Jankovic J
    J Neurol Sci; 2022 Feb; 433():120012. PubMed ID: 34642022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
    Williams DR; Warren JD; Lees AJ
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):652-5. PubMed ID: 17872984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medio-lateral balance impairment differentiates between Parkinson's disease and atypical parkinsonism.
    Nonnekes J; Aerts MB; Abdo WF; Bloem BR
    J Parkinsons Dis; 2014; 4(4):567-9. PubMed ID: 25125484
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.